Bullish Case: Dexcom's strong Q3 results, positive market response to its technology and products, and successful legal battles against competitors point towards growth [seekingalpha.com, juve-patent.com, drugdeliverybusiness.com].


Show historical bullish cases

Bearish Case: Insider selling, market skepticism, potential disruption from advanced obesity drugs, and a competitive landscape pose challenges and uncertainty [Helium, Helium, Helium].


Show historical bearish cases

Takeaway: Dexcom's Q3 results and expanding market presence enhance its growth prospects, but risks of insider selling and competition warrant close attention [seekingalpha.com, drugdeliverybusiness.com, juve-patent.com].


Show historical takeaways

Potential Outcomes:

1. Expansion of Dexcom’s product use, driven by successful integration with automated insulin tech and market demand (55% chance). This is based on success of G7 device and Dexcom-Tandem partnership [drugdeliverybusiness.com].

2. Continued turbulence in stock price due to market volatility and insider selling trends (30% chance) projected from [Helium, Helium].

3. Competing health tech products and potential obesity drug advancements disrupt Dexcom’s market share (15% chance), drawn from previous conjectures [Helium, Helium].


November 14, 2023


Dexcom Forecast

[DXCM]  Dexcom
Price Forecast: BULLISH    Price Action: MEAN REVERTING (?)



Make More Profitable Trades with DXCM Forecasts + Trading Strategies







DXCM Balanced News:












Become a more profitable trader with AI optimized trading strategies




Correlated Stock Forecasts

Assets that tend to move strongly with DXCM



YUM Forecast + Options Trading Strategies   [YUM]  Yum Brands (0.83)


EW Forecast + Options Trading Strategies   [EW]  Edwards Lifesciences (0.82)


IHI Forecast + Options Trading Strategies   [IHI]  BTC iShares U.S. Medical (0.81)


TGTX Forecast + Options Trading Strategies   [TGTX]  TG Therapeutics (0.74)


ALGT Forecast + Options Trading Strategies   [ALGT]  Allegiant Travel (0.73)



Uncorrelated Stock Forecasts

Assets with little price relationship to DXCM



BTCM Forecast + Options Trading Strategies   [BTCM]  BIT Mining Ltd - (-0.0)


BOOT Forecast + Options Trading Strategies   [BOOT]  Boot Barn (-0.0)


QID Forecast + Options Trading Strategies   [QID]  ProShares UltraShort QQQ (0.01)


MAC Forecast + Options Trading Strategies   [MAC]  Macerich (0.01)


SPTN Forecast + Options Trading Strategies   [SPTN]  SpartanNash (0.02)



Anticorrelated Stock Forecasts

Assets that tend to move strongly against DXCM



USO Forecast + Options Trading Strategies   [USO]  United States Commodity Funds (-0.67)


AMGN Forecast + Options Trading Strategies   [AMGN]  AMGEN (-0.69)


UCO Forecast + Options Trading Strategies   [UCO]  ProShares Ultra Bloomberg Crude Oil (-0.7)


SU Forecast + Options Trading Strategies   [SU]  Suncor Energy (-0.72)


X Forecast + Options Trading Strategies   [X]  United States Steel (-0.76)